Continental Grain is a provider of investment banking and financial support services.
Business Model:
Revenue: $2.6B
Employees: 10,001-999,999
Address: 767 5th Ave
City: New York
State: NY
Zip: 10153
Country: US
Continental Grain is a provider of investment banking and financial support services.
Contact Phone:
+12122075100
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2019 | MycoTechnology | Series C | 0 |
3/2022 | MycoTechnology | Series E | 0 |
6/2021 | Sentera | Series C | 0 |
9/2020 | Brightseed | Series A | 0 |
9/2020 | Brightseed | Venture Round | 27M |
1/2019 | Greenlight Biosciences | Venture Round | 50M |
9/2018 | Sentera | Series A | 14M |
5/2023 | Sentera | Series C | - |
1/2021 | Phospholutions | Series A | 0 |
9/2021 | Yuan Yao Nong Ye | Venture Round | 15.5M |
4/2021 | Stable | Series A | 0 |
1/2021 | Agrolend | Seed Round | 1.6M |
5/2022 | Stable | Series B | 0 |
1/2022 | Agrolend | Series A | 14M |
9/2018 | SmartAHC | Series A | 2.9M |
7/2021 | Prenexus Health | Series B | 0 |
10/2018 | Pivot Bio | Series B | 70M |
9/2021 | Agot.AI | Seed | 10M |
8/2022 | Pattern Ag | Series B | 35M |
6/2020 | Greenlight Biosciences | Series D | 102M |
8/2017 | MycoTechnology | Series B | 0 |
8/2017 | Impossible Foods | Convertible Note | 100M |
8/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
8/2017 | UPSIDE Foods | Series A | 17M |
7/2021 | Pivot Bio | Series D | 0 |
4/2020 | Pivot Bio | Series C | 0 |
12/2019 | Bushel | Series B | 0 |
2/2018 | Perfect Day | Series A | 0 |
3/2021 | Cérélia Group | Corporate Round | - |
2/2021 | Vestaron | Series B | 0 |
4/2021 | Bushel | Series C | 0 |
8/2022 | Vestaron | Series C | 0 |
6/2019 | Vestaron | Series B | 0 |
5/2022 | Vestaron | Series C | 0 |
1/2022 | Agroberries | Venture Round | - |
3/2021 | Agrolend | Seed Round | 1.6M |
6/2016 | Modern Meadow | Series B | 40M |
11/2021 | Plasma Nutrition | Series A | - |
2/2020 | Ceva Santé Animale | Venture Round | - |
1/2021 | Ukko | Series B | 0 |
2/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
11/2022 | Agrolend | Series B | 28M |
11/2018 | ItsaCheckmate | Series A | 3M |
5/2022 | Brightseed | Series B | 0 |
6/2020 | MycoTechnology | Series D | 0 |
12/2021 | DMC Biotechnologies | Series B | 0 |
4/2021 | EAVISION | Series C | 30M |
9/2017 | RBT | Post-IPO Equity | 2.9M |
5/2022 | Stable | Series B | 0 |
5/2022 | Brightseed | Series B | 0 |
3/2022 | MycoTechnology | Series E | 0 |
2/2022 | Greenlight Biosciences | Post-IPO Equity | 0 |
1/2022 | Agrolend | Series A | 0 |
1/2022 | Agroberries | Venture Round | - |
12/2021 | DMC Biotechnologies | Series B | 0 |
11/2021 | Plasma Nutrition | Series A | - |
9/2021 | Agot.AI | Convertible Note | 0 |
9/2021 | Yuan Yao Nong Ye | Venture Round | 0 |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|